Special Investigation - Efficacy/Safety Evaluation of Clarithromycin in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

Special Investigation - Efficacy/Safety Evaluation of Clarithromycin in Patients With Non-tuberculous Mycobacterial Pulmonary Infections - Special Investigation of Clarithromycin in Patients With Non-tuberculous Mycobacterial Pulmonary Infections

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000011271

Enrollment

200

Registered

2013-07-25

Start date

2008-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NTM Pulmonary Infections

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients given a diagnosis of NTM on the basis of criteria established by the Japanese Society for Tuberculosis (2008 Revision)

Exclusion criteria

Exclusion criteria: (i) Patients with HIV-1 infection (ii) Patients whose pneumonia recurred within CAM treatment (iii) Patients enrolled in entry of the study (iv) Patients whose diseases have contraindication against the CAM

Design outcomes

Primary

Measure	Time frame
Evaluation of adverse event, Rate of bacterial eradication	—

Countries

Japan

Outcome results